Isracann Biosciences Inc
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 231.08 | -100% | -1.33 | -100% |
| P/S |
|
0 | 12.89 | -100% |
|
|
| P/BV |
|
0 | 3.54 | -100% |
|
|
| P/FCF |
|
0 | 8.45 | -100% |
|
|
| Ev/Ebitda |
|
0 | 11.15 | -100% |
|
|
| Ev/S |
|
0 | 7.91 | -100% |
|
|
| Ev/FCF |
|
0 | 0.56 | -100% |
|
|
| E/P |
|
0 | 0.59 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | -575.06 | -100% | -216.17 | -100% |
| ROE |
|
0 | 9.99 | -100% |
|
|
| ROA |
|
0 | 0.43 | -100% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
0 | -584.53 | -100% |
|
|
| ROCE |
|
0 | 19.37 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0 | 3.4 | -100% | 0 | 0% |
| Nеt Debt/Ebitda |
|
0 | 3.08 | -100% |
|
|
| Debt/Ratio |
|
0 | 0.28 | -100% |
|
|
| Debt/Equity |
|
0 | 1.7 | -100% |
|
|
| Debt/Net Income |
|
0 | 73.91 | -100% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 4.25 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.94 | -100% | ||
| DSI |
|
0 | 0.72 | -100% |
|
|
| Average dividend growth |
|
0 | 8.31 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 4.3 | -100% |
|
|
| Average percentage for payments |
|
0 | 100.91 | -100% |
|
|
| Difference from average difference in sector |
|
-4.25 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
3318.69 | 854.45 | 288.4% | ||
| Growth impulse Ebitda in 5 years |
|
-31.66 | 387.64 | -108.17% | ||
| Growth impulse Net Income in 5 years |
|
-37.21 | 727.64 | -105.11% | ||
| Growth impulse FCF in 5 years |
|
-80.33 | 1802.55 | -104.46% | ||
| Growth impulse EPS in 5 years |
|
-80.59 | 6659.13 | -101.21% |
IP Score
2.9/10
